A detailed history of Quintet Private Bank (Europe) S.A. transactions in Novo Nordisk A S stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 9,389 shares of NVO stock, worth $1.09 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
9,389
Previous 9,543 1.61%
Holding current value
$1.09 Million
Previous $1.41 Billion 11.87%
% of portfolio
0.09%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$122.71 - $146.91 $18,897 - $22,624
-154 Reduced 1.61%
9,389 $1.57 Billion
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $565,995 - $753,404
5,543 Added 138.58%
9,543 $1.41 Billion
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $271,819 - $596,425
2,989 Added 295.65%
4,000 $364 Million
Q2 2023

Aug 09, 2023

BUY
$155.98 - $172.65 $157,695 - $174,549
1,011 New
1,011 $161 Million
Q2 2022

Aug 09, 2023

BUY
$103.24 - $121.81 $104,375 - $123,149
1,011 New
1,011 $161 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $263B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Quintet Private Bank (Europe) S.A. Portfolio

Follow Quintet Private Bank (Europe) S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quintet Private Bank (Europe) S.A., based on Form 13F filings with the SEC.

News

Stay updated on Quintet Private Bank (Europe) S.A. with notifications on news.